Patents by Inventor Thomas Gordon

Thomas Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10813197
    Abstract: A lighting controller comprises power circuitry, transmitter circuitry, a touch-sensitive panel, and processing circuitry. The power circuitry is configured to relay power from the lighting controller to a solid state lighting fixture wired to the lighting controller. The transmitter circuitry is configured to wirelessly exchange signals with the solid state lighting fixture. The touch-sensitive panel is configured to emit light and receive touch input from a user. The processing circuitry is electrically coupled to the power circuitry, the transmitter circuitry, and the touch-sensitive panel. The processing circuitry is configured to wirelessly control, via the transmitter circuitry, the attribute of light emitted by the solid state lighting fixture in accordance with the touch input received via the touch-sensitive panel and control the light emitted from the touch-sensitive panel to indicate the attribute as the attribute is wirelessly controlled.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: October 20, 2020
    Assignee: IDEAL INDUSTRIES LIGHTING LLC
    Inventors: Bart Reier, Daniel James Van Epps, Jr., Yuan Fang, David Power, Leigh Herman, Thomas Gordon
  • Publication number: 20180295705
    Abstract: A lighting controller comprises power circuitry, transmitter circuitry, a touch-sensitive panel, and processing circuitry. The power circuitry is configured to relay power from the lighting controller to a solid state lighting fixture wired to the lighting controller. The transmitter circuitry is configured to wirelessly exchange signals with the solid state lighting fixture. The touch-sensitive panel is configured to emit light and receive touch input from a user. The processing circuitry is electrically coupled to the power circuitry, the transmitter circuitry, and the touch-sensitive panel. The processing circuitry is configured to wirelessly control, via the transmitter circuitry, the attribute of light emitted by the solid state lighting fixture in accordance with the touch input received via the touch-sensitive panel and control the light emitted from the touch-sensitive panel to indicate the attribute as the attribute is wirelessly controlled.
    Type: Application
    Filed: April 10, 2017
    Publication date: October 11, 2018
    Inventors: Bart Reier, Daniel James Van Epps, JR., Yuan Fang, David Power, Leigh Herman, Thomas Gordon
  • Patent number: 7649468
    Abstract: A system comprising at least one liquid detector that has a cathode and an anode and at least one switching mechanism for receiving a positive voltage from the cathode and anode of a liquid detector. Each switching mechanism comprises at least one switching component that is connected with a power source. Each switching component supplying a current from its connected power source when the switching component is activated. Preferably, each switching component is activated, when the switching component receives a voltage that exceeds a threshold voltage. The system also comprises a base unit that communicates remotely or through direct connection with each switching mechanism. The base unit communicates with at least one application control device that is connected with at least one electronic control apparatus for preventing the undesirable condition.
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: January 19, 2010
    Inventor: Thomas Gordon
  • Publication number: 20090270341
    Abstract: A composition for treating cancer comprising an anti-tumorally effective amount of a product comprising at least one transduction inhibitor of heterotrimeric G protein signals and at least one other anti-cancer agent selected from the group consisting of prenyltransferase inhibitors, taxol and its analogues, gemcitabine and camptothecin and its analogues, administered simultaneously, separately or spread over a period of time and a pharmaceutical carrier.
    Type: Application
    Filed: July 2, 2009
    Publication date: October 29, 2009
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Gregoire PREVOST, Marie-Odile Lonchampt, Thomas Gordon, Barry Morgan
  • Publication number: 20070299073
    Abstract: The present invention is directed to imidazolyl derivatives of formula (I) where the substituents are defined in the specification, which are useful as agonist or antagonists of somatostatin receptors.
    Type: Application
    Filed: May 22, 2007
    Publication date: December 27, 2007
    Inventors: Christophe Thurieau, Lydie Poitout, Marie-Odile Galcera, Thomas Gordon, Barry Morgan, Christophe Moinet
  • Publication number: 20070282101
    Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
    Type: Application
    Filed: April 2, 2007
    Publication date: December 6, 2007
    Inventors: Anna Ericsson, Andrew Burchat, Kristine Frank, David Calderwood, Lily Abbott, Maria Argiriadi, David Borhani, Kevin Cusack, Richard Dixon, Thomas Gordon, Kelly Mullen, Robert Talanian, Xiaoyun Wu, Xiaolei Zhang, Lu Wang, Biqin Li, Claude Barberis, Neil Wishart
  • Publication number: 20070032653
    Abstract: The present invention is directed to imidazolyl derivatives of formula (I) where the substituents are defined in the specification, which are useful as agonists or antagonists of somatostatin receptors.
    Type: Application
    Filed: July 31, 2001
    Publication date: February 8, 2007
    Inventors: Christophe Thurieau, Lydie Poitout, Marie-Odile Galcera, Thomas Gordon, Barry Morgan, Christopher Moinet, Dennis Bigg
  • Publication number: 20060266104
    Abstract: A system is disclosed for detecting moisture in a garment. The system comprises at least one moisture detection portion integrated with the garment. Each moisture detection portion comprises a cathode and an anode and may also comprise a housing or panel surrounding the electrodes. The system also comprises at least one switching mechanism for receiving a positive voltage from the cathode and the anode of a moisture detection portion, when the cathode and the anode are in the presence of a polar liquid. Each switching mechanism comprises at least one switching component and at least one power source. Each switching mechanism supplies current from at least one of its power sources to at least one notification device or at least one transmitter, or both, when its switching components are activated.
    Type: Application
    Filed: May 31, 2005
    Publication date: November 30, 2006
    Inventor: Thomas Gordon
  • Publication number: 20060252760
    Abstract: A family of compounds capable of inhibiting the activity of farnesyl transferase.
    Type: Application
    Filed: May 30, 2006
    Publication date: November 9, 2006
    Inventors: Thomas Gordon, Barry Morgan
  • Publication number: 20060209161
    Abstract: A donor web for use in a thermal transfer printer comprises a foil having a transfer side and a non-transfer side. A layer of thermal transfer material is disposed on the transfer side of the foil material. Indicia is ink-jetted to the foil. The indicia includes information pertaining to at least one of the length of used foil and the length of unused foil so that an operator can determine whether there is enough foil left for a printing operation. Preferably, the indicia is disposed on the non-transfer side and at a longitudinal edge portion of the foil in order to not affect or otherwise damage the printing portion of the foil. Also, the indicia is preferably white or black ink in order to be clearly visible against various colors of the thermal transfer material. The indicia can also be disposed on a receiver web.
    Type: Application
    Filed: March 29, 2004
    Publication date: September 21, 2006
    Inventors: Mark Godden, Lisa Brant, Thomas Gordon
  • Publication number: 20060159547
    Abstract: Aspects of the invention related to a system for providing advance notice of impending contact between a stationary component and a rotating component in a turbine engine. For example, the system can be used to warn of potential contact between a seal holder and a rotor disk in the compressor section of the engine. In one embodiment, a pad or other component can be provided on the stationary seal holder. If the seal holder and the rotor disk approach each other during operation, the pad can contact the rotor disk prior to actual contact between the seal holder and the rotor disk. An optical and/or an acoustic signal can be generated by such contact. The signals can be detected remotely from the point of contact by a signal detection device, thereby avoiding the need to pass wires through the compressor section.
    Type: Application
    Filed: January 15, 2005
    Publication date: July 20, 2006
    Inventors: Thomas Gordon, William Ryan, Lawrence Ross, Brian Ottinger, Richard Holm, Nicholas D'Amico, Phillip Gravett, Nancy Ulerich
  • Publication number: 20060151453
    Abstract: A contact tip suitable for electric arc welding has a consumable electrode. The contact tip has a body which defines a bore through which the electrode is able to pass to enable electric current from a welding power supply to be transferred from the body to the electrode. The body, in part of the length of the bore between an inlet end and an outlet end, has at least one region (herein referred to as a primary contact region) at which the body is adapted to enable primary electrical contact with the electrode, and along a remainder part of the length of the bore, the body is adapted such that any secondary contact between the body and the electrode along the remainder part does not substantially short circuit the primary electrical contact in the primary contact region of the bore.
    Type: Application
    Filed: April 27, 2004
    Publication date: July 13, 2006
    Inventors: Thomas Gordon, Bernard Bednarz, Mark Neller, Michael Fanning, Srinivasarao Lathabai
  • Publication number: 20060142275
    Abstract: A family of imidazole compounds useful for inhibiting the activity of prenyl transferases. The compounds are covered by the following formula: wherein X is (CHR11)n3(CH2)n4Z(CH2)n5 where Z is O, N(R12), S, or a bond; Y is CO, CH2, CS, or a bond; R1 is or N(R24R25); and the remaining substituents are as defined in the disclosure.
    Type: Application
    Filed: February 14, 2006
    Publication date: June 29, 2006
    Inventors: Thomas Gordon, Barry Morgan
  • Patent number: 7034024
    Abstract: The invention concerns a product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent, in particular farnesyltransferase inhibitors, taxol or gemcitabin, for simultaneous, separate or prolonged therapeutic use in cancer treatment.
    Type: Grant
    Filed: November 8, 2000
    Date of Patent: April 25, 2006
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Grégoire Prevost, Marie-Odile Lonchampt, Thomas Gordon, Barry Morgan
  • Patent number: 7034025
    Abstract: A method of treating cholera or travel diarrhea in a patient in need thereof by an effective amount of a compound of the formula wherein the substrates are defined in the specification or its non-toxic, pharmaceutically acceptable salts.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: April 25, 2006
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Grégoire Prevost, Marie-Odile Lonchampt, Thomas Gordon
  • Publication number: 20060079530
    Abstract: A family of compounds capable of inhibiting the activity of farnesyl transferase.
    Type: Application
    Filed: November 28, 2005
    Publication date: April 13, 2006
    Inventors: Thomas Gordon, Barry Morgan
  • Publication number: 20060074078
    Abstract: A composition for treating cancer comprising an anti-tumorally effective amount of a product comprising at least one transduction inhibitor of heterotrimeric G protein signals and at least one other anti-cancer agent selected from the group consisting of prenyltransferase inhibitors, taxol and its analogues, gemcitabine and camptothecin and its analogues, administered simultaneously, separately or spread over a period of time and a pharmaceutical carrier.
    Type: Application
    Filed: November 10, 2005
    Publication date: April 6, 2006
    Inventors: Gregoire Prevost, Marie-Odile Lonchampt, Thomas Gordon, Barry Morgan
  • Publication number: 20060074102
    Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
    Type: Application
    Filed: May 13, 2005
    Publication date: April 6, 2006
    Inventors: Kevin Cusack, Jose-Andres Salmeron-Garcia, Thomas Gordon, Claude Barberis, Hamish Allen, Agniezka Bischoff, Anna Ericsson, Michael Friedman, Dawn George, Gregory Roth, Robert Talanian, Christine Thomas, Grier Wallace, Neil Wishart, Zhengtian Yu
  • Publication number: 20060069017
    Abstract: Claimed is a somatostatin agonist according to formula (I), D-Phe-c(Cys-Tyr(I)-D-Trp-Lys-Val-Cys)-Thr-NH2,??(I) or a pharmaceutically acceptable salt thereof, and uses thereof.
    Type: Application
    Filed: November 8, 2005
    Publication date: March 30, 2006
    Inventors: Thomas Gordon, Barry Morgan, Michael Culler
  • Publication number: 20060035899
    Abstract: The invention relates to the use of cysteine derivatives for preparing a medicament intended to treat diseases which result from the formation of the heterotrimeric G protein. These diseases include in particular diseases linked to the following biological functions or disorders: smell, taste, perception of the light, neurotransmission, neurodegeneration, endocrine and exocrine gland functions, autocrine and paracrine regulation, arterial tension, embryogenesis, benign cell proliferation, oncogenesis, viral infection, immunological functions, diabetes, obesity, and benign :and malign proliferative diseases. Said cysteine derivatives include in particular: bis-1,1?-[7-(2-amino-1-oxo-3-thiopropyl)-8-(cyclohexylmethyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1.2a]pyrazine disulphide (I), and bis-1,1?-7-(2-amino-1-oxo-3-thiopropyl-(2-(1-naphtyl)-8-(2-methylpropyl)-5,6,7,8-tetrahydroimidazo[1.2a]pyrazin-7-yl) disulphide (II).
    Type: Application
    Filed: September 9, 2005
    Publication date: February 16, 2006
    Inventors: Gregoire Prevost, Marie-Odile Lonchampt, Thomas Gordon